Mercaptopurine Suspension
Product Images NDC 62484-1020

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Mercaptopurine (NDC 62484-1020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nova Laboratories, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Figure1)

Chemical structure of mercaptopurine, showing its molecular arrangement including sulfur, nitrogen, hydrogen, carbon atoms, and associated bonds.*

FDA Label Image

Purixan Bottle Label (Bottle Label)

Label for Mercaptopurine oral suspension, 20 mg/mL (2000 mg/100 mL) manufactured by Nova Laboratories Ltd for Rare Disease Therapeutics, Inc. The label includes instructions to shake vigorously before use, storage directions, and warnings to keep out of reach of children. The product is supplied in a 100 mL bottle and includes a barcode and NDC 62484-1020-3.*

FDA Label Image

Purixan Carton Label (Carton Label)

Packaging label for Mercaptopurine oral suspension, 20 mg/mL (2000 mg/100 mL) by Nova Laboratories, Ltd. The carton displays the product name, dosage form, strength, and usage instructions including shaking vigorously before use. It includes manufacturing details, storage conditions, package contents, an indication that it is Rx only, and Braille text. The label also shows measurement and color specification details for printing.*

FDA Label Image

Figure A (Nova 04)

Illustration showing a hand holding a bottle, shaking it up and down as indicated by motion lines and arrows, likely demonstrating how to prepare an oral liquid medication suspension before use.*

FDA Label Image

Figure B (Nova 05)

An instructional illustration showing two hands demonstrating the action of pressing down and twisting, likely indicating how to open a child-resistant bottle cap by pushing down while turning.*

FDA Label Image

Figure C (Nova 06)

An instructional illustration showing a person holding an oral suspension bottle and pressing down on the cap, indicating how to open or close the child-resistant cap on the medication bottle.*

FDA Label Image

Figure E (Nova 07)

An instructional illustration showing a hand inserting or removing a dosing syringe into or from an oral suspension bottle. The image emphasizes proper use of the syringe for measuring liquid medication from the bottle.*

FDA Label Image

Figure F (Nova 08)

An instructional illustration showing a hand holding a bottle of oral medication suspension, with an arrow indicating the downward placement of a syringe into the bottle for withdrawal of the dose.*

FDA Label Image

Figure D (Nova 09)

An instructional illustration depicting a hand holding a syringe. The syringe components are labeled, pointing out the plunger, barrel, and tip. The image provides guidance on the parts of a syringe used for administering medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.